• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties Chronic Disease

Physical activity is associated with a reduction in all-cause mortality in patients with newly diagnosed Parkinson Disease

byMeagan WiedermanandMichael Pratte
November 5, 2021
in Chronic Disease, Neurology, Public Health
Reading Time: 3 mins read
Share on FacebookShare on TwitterShare on LinkedIn

1. Newly diagnosed Parkinson Disease patients who were active had an associated reduced all-cause mortality compared to those who were inactive.

2. Activity of any intensity level was associated with reduced mortality, with progressively greatest reduction at longer and more intense (greater metabolic equivalents) activity.

Evidence Rating Level: 2 (Good)

Study Rundown: There are few disease-modifying treatments for Parkinson Disease (PD) currently supported by evidence. Physical activity (PA) has been associated with decreasing the risk of development or progression of PD. Thus, PA may be a potential disease-modifying therapeutic option for PD. This study evaluated whether PA decreased all-cause mortality of PD patients. Data on demographics and PD diagnosis were taken from the Korean National Health Insurance Service (NHIS) database. PA was collected from a 7-day recall and reported as total metabolic equivalent of task (MET) minutes/week, where 3, 5, and 8 METs were light, moderate, and intense exercise. 10,699 PD patients (54% women, 46% men, age = 69.2±8.8 years) were followed for 4.5±1.4 years. Increased mortality was associated with higher age, being male, high BMI, high disability, and comorbidities. Participants who died had, on average, less PA than those who did not. PD patients who were active had an associated reduced mortality compared to those who were inactive. Activity of any intensity reduced mortality, with longer and greater METs progressively reducing mortality. One limitation of this study is the high potential for selection bias for participants with health-seeking behaviours given the inclusion criteria of having regular health checkups to assess PA. Given the 7-day recall sampling of PA, recall bias could exist. Additionally, there could be sampling error if the 7-day recall weeks were not representative of the individuals’ PA. Finally, subtypes of PD symptoms, anti-PD medications, and other habits like caffeine consumption, diet, and smoking were not available in this database for analysis or to be removed as potential confounders for their known association with PD and effects on mortality.

Click to read the study in JAMA Neurology

Click to read an accompanying editorial in JAMA Neurology

RELATED REPORTS

Visual perturbation training may be superior to treadmill training for reduction of fall risk in Parkinson’s disease

2 Minute Medicine Rewind March 9, 2026

Relevant Reading: Tai chi and postural stability in patients with Parkinson’s disease

FDA approvedFor Parkinson disease: Juvmo (tavapadon), Sep 25, 2026→

In-Depth [retrospective cohort]: Patients older than 40 with newly diagnosed PD who attended check-ups 2 years before and after diagnosis were identified in the Korean NHIS database. A 7-day recall of PA (type and intensity) is reported in this database at each checkup. These PAs were converted into total MET minutes/week and classified as light, moderate, or intense/vigorous. Patients were then classified as active or inactive if they met a threshold of PA. Vigorous activity included any high-intensity PA like running, fast biking, aerobatics, or climbing for at least 20 minutes; moderate activity included moderate-intensity PA like fast walking, riding a bicycle at a normal speed, and doubles tennis for at least 30 minutes; finally, light activity included any light-intensity PA like walking for at least 30 minutes. Patients were defined as physically active if they completed at least 3 days of intense or at least 5 days of light PA. Of the 10,699 participants, those who died were more likely to be older (73.2±7.5 years vs 68.3±8.8 years; P < 0.001). Women were more likely to be among those who did not die compared to those who did (39.6% vs 56.9%; P < 0.001). Increased mortality was associated with higher age (HR = 1.07, 95%CI = 1.06-1.07; P < 0.001), disability (HR = 1.92, 95% CI = 1.66-2.23; P < 0.001), and Charlson Comorbidity Index (HR = 1.13, 95% CI = 1.11-1.16; P < 0.001). Decreased mortality was associated with female sex (HR = 0.53, 95% CI = 0.48-0.58; P < 0.001) and BMI (HR, 0.94, 95% CI = 0.92-0.95; P < 0.001). The average participant who died performed 270 MET-minutes/week of PA, while those who did not performed 450 MET-minutes/week. Patients with PD who were physically active compared to inactive had an associated reduced mortality by log-rank test (P < 0.001). The risk of death for PD patients was reduced for all PA levels (vigorous: HR = 0.80, 95% CI = 0.69-0.93; moderate-intensity: HR = 0.66, 95% CI = 0.55-0.78; light-intensity: HR = 0.81, 95% CI = 0.73-0.90). PD patients in the first compared to the fourth quartile range had progressively decreasing risk of mortality (HR = 0.61, 95% CI = 0.53-0.70; P < 0.001). Those active before and after PD diagnosis had the greatest mortality rate reduction compared to those who were always inactive (vigorous: HR = 0.66, 95% CI = 0.50-0.88; moderate: HR = 0.49, 95% CI = 0.32-0.75; light: HR = 0.76, 95% CI = 0.66-0.89). Individuals who became active when they were diagnosed experienced a mortality reduction (vigorous: HR = 0.82, 95% CI = 0.70-0.97; moderate: HR = 0.69, 95% CI = 0.57-0.83; light: HR = 0.86, 95% CI = 0.78-0.98), while those who became inactive had similar mortality rates to those who were always inactive.

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: parkinsonParkinson DiseaseParkinson’sParkinson’s Disease
Previous Post

#VisualAbstract: Exemestane plus etinostat does not improve survival compared to exemestane alone for HR⁺ advanced breast cancer

Next Post

Similar clinical outcomes for targeted temperature management at 31C versus 34C in cardiac arrest survivors

RelatedReports

Physical activity collage: an engraved bicycle, a water bottle lying on its side and a path of flat stepping stones
Chronic Disease

Visual perturbation training may be superior to treadmill training for reduction of fall risk in Parkinson’s disease

March 10, 2026
Brain health collage: an engraved brain in side view, a branching neuron, a plain brain-slice silhouette and a reflex hammer
Weekly Rewinds

2 Minute Medicine Rewind March 9, 2026

March 9, 2026
Chronic conditions collage: a smiling older man in a plaid shirt with small teal dots along his cheek and a cup of coffee
2 Minute Medicine

Machine learning models effectively screened for Parkinson’s disease using smile videos

December 29, 2025
Pressure ulcers collage: a hospital air mattress holding a padded heel boot and a foam wedge, beside a pleated paper cup
Chronic Disease

Drug-related pressure ulcers may be characterised by medication-related characteristics such as polypharmacy and medication changes rather than baseline immobility

January 13, 2026
Next Post

Similar clinical outcomes for targeted temperature management at 31C versus 34C in cardiac arrest survivors

Prescription of tramadol is associated with higher rates of adverse clinical outcomes compared to codeine in patients with chronic, noncancer pain

Women with pregnancy-associated melanoma at greater risk of metastasis, recurrence

2 Minute Medicine Rewind November 8, 2021

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Early mitral valve surgery may improve long-term survival in asymptomatic severe mitral regurgitation
  • CDC reports increasing early-season influenza activity and at least 900 deaths nationwide
  • A concentrated exposure therapy intervention may be more effective than digital cognitive behavioural therapy in obsessive-compulsive disorder
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
    • ICD-10 Code Lookup
    • Medical School Rankings
    • FDA Drug Approvals
    • Drug Safety for Breastfeeding/Pregnancy
    • Clinical Guidelines
    • Medical Calculators
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.